Free Cash Flow (Quarterly) Chart

Historical Free Cash Flow (Quarterly) Data

View and export this data back to 2013. Start Trial.
Date Value
June 30, 2026 -3.112M
March 31, 2026 -2.484M
December 31, 2025 -3.039M
September 30, 2025 -2.102M
June 30, 2025 -3.302M
March 31, 2025 -2.15M
December 31, 2024 -2.124M
September 30, 2024 -1.49M
June 30, 2024 -4.894M
March 31, 2024 -4.044M
March 31, 2023 -4.88M
June 30, 2022 -8.574M
March 31, 2022 -5.050M
December 31, 2021 -5.004M
September 30, 2021 -1.559M
June 30, 2021 -4.866M
March 31, 2021 -7.418M
December 31, 2020 -4.233M
September 30, 2020 -0.7042M
June 30, 2020 -4.274M
March 31, 2020 -7.740M
Date Value
December 31, 2019 -3.464M
September 30, 2019 -4.910M
June 30, 2019 -4.772M
March 31, 2019 0.2289M
December 31, 2018 -4.567M
September 30, 2018 -5.331M
June 30, 2018 -8.284M
March 31, 2018 -4.398M
December 31, 2017 -8.517M
September 30, 2017 -9.214M
June 30, 2017 -4.73M
March 31, 2017 -9.174M
December 31, 2016 -6.395M
September 30, 2016 -4.999M
June 30, 2016 -6.080M
March 31, 2016 -7.100M
December 31, 2015 -6.768M
September 30, 2015 5.172M
June 30, 2015 -1.316M
March 31, 2015 -2.064M
December 31, 2013 -4.198M

Free Cash Flow Definition

Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.

Read full definition.

Free Cash Flow (Quarterly) Range, Past 5 Years

View Free Cash Flow (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow (Quarterly) Benchmarks

View Free Cash Flow (Quarterly) Benchmarks
Start Trial
DBV Technologies SA -49.68M
Cellectis SA -14.59M
Bicycle Therapeutics Plc -49.96M
argenx SE --
Autolus Therapeutics Plc -26.08M